Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. News
  7. Summary
    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SANOFI : Credit Suisse keeps its Buy rating

07/30/2021 | 07:17am EDT

Credit Suisse is positive on the stock with a Buy rating. The target price continues to be set at EUR 96.


ę MarketScreener with dpa-AFX Analyser 2021
All news about SANOFI
09/24SANOFI : Availability of the Q3 2021 Memorandum for modelling purposes
AQ
09/23SANOFI : New Dupixent« (dupilumab) data in patients as young as 6 years old with moderate-..
PU
09/23VC DAILY : Biotechs Seek New Skill Set From -2-
DJ
09/23SANOFI : Deutsche Bank keeps a Sell rating
MD
09/22PRESS RELEASE : Pfizer and BioNTech Expand -3-
DJ
09/21SANOFI : New Dupixent« (dupilumab) data in patients as young as 6 years old with moderate-..
AQ
09/20SANOFI : - ESMO late-breaking data show Libtayo (cemiplimab) and chemotherapy first-line t..
AQ
09/20PRESS RELEASE : Pfizer and BioNTech Announce -3-
DJ
09/20SANOFI : Regeneron, Sanofi Say Lung Cancer Drug Libtayo Improves Overall Patient Survival ..
MT
09/20SANOFI : Regeneron's Libtayo Combo Extends Lung Cancer Patients' Lives In Phase 3 Study
MT
More news
Analyst Recommendations on SANOFI
More recommendations
Financials
Sales 2021 37 415 M 43 855 M 43 855 M
Net income 2021 6 046 M 7 086 M 7 086 M
Net Debt 2021 7 878 M 9 234 M 9 234 M
P/E ratio 2021 17,2x
Yield 2021 4,01%
Capitalization 103 B 121 B 121 B
EV / Sales 2021 2,96x
EV / Sales 2022 2,70x
Nbr of Employees 99 412
Free-Float 88,4%
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 82,02 €
Average target price 104,66 €
Spread / Average Target 27,6%
EPS Revisions
Managers and Directors
Paul Hudson Chief Executive Officer & Director
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Serge Weinberg Chairman
John C. Reed EVP & Global Head-Research & Development
Nestle Frank Global Head-Immunology Therapeutic Research Area
Sector and Competitors
1st jan.Capi. (M$)
SANOFI4.22%120 553
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037